Finn
BBUC Diversified Industrials · Brookfield · Private equity · Capital recycling · Thesis updated November 8, 2026

Aggressive capital recycling balances weak spots and heavy debt

01 Running thesis

Recycling capital while risks brew

The bull case focuses on execution. BBUC continues to aggressively recycle capital, generating $1.4 billion in proceeds so far this year against a $2 billion target. This includes the completed sale of Multiplex for over $600 million. Management is using that cash to buy businesses, deploy strategic investments like the $100 million into enterprise AI platform DeployCo, and buy back shares at a steep discount to net asset value.

Clarios remains a critical anchor. The battery maker is unlocking massive value, having monetized its Interstate stake for roughly $1 billion. It is also expanding its market reach by providing supercapacitors to address the rising power needs of AI data centers.

The bear case centers on deteriorating fundamentals at several key holdings. CDK Global is dealing with distressed debt levels, and management is in active dialogue regarding the upcoming maturity. Meanwhile, Sagen is building reserves as the Canadian housing market softens, and the infrastructure segment is seeing operational struggles at Modulaire and Scientific Games.

The next upside tests are continued progress on asset sales and potential monetization events for Clarios. The downside test is whether the debt situation at CDK Global forces a formal restructuring that drags down broader portfolio gains.

Nov 2026→Q3 2026 earnings highlighted $1.4 billion in year-to-date capital recycling and value unlocks at Clarios. However, the bear case grew as Infrastructure Services showed operational softness and CDK Global debt remained distressed.
Jul 2026→Q2 2026 earnings showed strong capital recycling with $1.2 billion in proceeds, funding acquisitions and share repurchases. However, risks heightened with Sagen's loss ratio hitting 17 percent and reported lender negotiations at CDK Global.
May 2026▲Clarios received $1 billion of cash tax credits and the corporate simplification was complete, which de-risked the upside. The same update made CDK and Sagen risks more visible.
Mar 2026▲Healthscope entered receivership and was deconsolidated, removing a major drag from the reported portfolio. The filing also confirmed the March 2026 simplification.
Jan 2026▲La Trobe regulatory issue was resolved and inflows improved, turning it back into a monetization candidate. Management also said a BRK Ambiental listing was being strongly evaluated.
Nov 2025→BBUC closed First National and announced the plan to simplify the listed structure. CDK modernization costs and delayed Clarios tax credit processing kept the risk side in focus.
Aug 2025▲Brookfield sold partial interests in three businesses to an evergreen fund for units with $690 million of initial redemption value. That supported the capital recycling story while DexKo and modular demand stayed soft.
May 2025→BBUC added Antylia Scientific and a Barclays Payments investment while buying back shares. CDK costs and DexKo tariff exposure kept the update balanced.
02 Business model

A public private equity engine

BBUC is a publicly listed way to own part of Brookfield's private business portfolio. It buys companies that provide essential products or services, improves their operations, then exits, sells partial stakes, or refinances them.

Money comes from operating earnings, dividends, refinancing proceeds, and asset sales. The model works best when Brookfield buys at a low price, cuts costs, grows cash flow, then sells at a higher value.

Management increasingly treats the company like a publicly listed private equity secondary fund. They use secondary sales, often selling partial stakes to affiliated funds, to turn private value into cash. That can highlight value when the public stock trades cheaply, but it also requires investors to trust Brookfield's internal marks on private assets.

The model breaks when debt is too heavy, exit markets shut down, or an operating company needs more money than planned. That is why the ongoing debt distress at CDK Global and the interest rate environment matter so much.

03 Product portfolio

Many businesses, uneven quality

Growth engine

Clarios

Clarios makes advanced energy storage products. It is expanding into AI data center power and monetizing assets to drive significant value.

Steady

DexKo

DexKo makes engineered components for trailers. It is exposed to weak volumes and tariff pressures, making it highly sensitive to macroeconomic cycles.

Option

CDK Global

CDK sells software to auto dealers. Distressed debt levels, modernization costs, and creditor pressures make it a significant risk.

Cash cow

Sagen

Sagen provides Canadian residential mortgage insurance. It remains profitable, but a weakening Canadian housing market is forcing it to increase reserves.

Steady

Modulaire

Modulaire provides modular workspace solutions. It is currently facing softer demand, competitive pricing pressures, and operational challenges in the U.K. market.

Option

DeployCo

DeployCo is an enterprise AI deployment investment. BBUC holds a $100 million syndicated position to drive operational efficiencies across its portfolio.

04 Business segments

Industrial assets lead revenue

Industrials54%modest
Business Services34%declining
Infrastructure Services12%flat

FY 2025 revenue mix is based on reported segment revenue of $14.9 billion for Industrials, $9.4 billion for Business Services, and $3.2 billion for Infrastructure Services.

05 Risk factors

What could break the case

CDK value leakage and debt maturity

High impact · High odds

CDK Global is the most visible stress point. Debt is trading at distressed levels, and management is in active dialogue regarding the upcoming maturity. A formal restructuring would destroy equity value.

We watchWatch for creditor actions, debt amendments, and formal restructuring announcements.

Canadian housing losses at Sagen

Medium impact · High odds

Sagen is strengthening its reserves as the Canadian housing market weakens, particularly in Ontario. While management expects the loss ratio to stabilize, a deeper housing correction would amplify the damage.

We watchWatch Sagen loss ratios, Canadian house prices, and mortgage delinquency trends.

Cyclical pressure at DexKo

Medium impact · High odds

DexKo is tied to demand cycles for engineered components. Weak volumes reduce operating leverage, and tariffs add cost pressure. Cost cuts help, but they may not offset a long slump in demand.

We watchWatch DexKo volume commentary, tariff cost pass-through, and macro end-market demand.

Infrastructure operational struggles

Medium impact · Medium odds

Infrastructure Services faces new headwinds with softer demand and pricing pressure at Modulaire in the U.K., alongside higher delivery costs for international contracts at Scientific Games.

We watchWatch margin commentary for Modulaire and Scientific Games in future earnings updates.
06 Quick answers

In one breath

Is BBUC the same as Brookfield Business Partners?

BBUC is the corporate share form tied to Brookfield Business Partners. In March 2026, Brookfield simplified the structure so holders received shares in one new publicly traded Canadian corporation.

Why does Clarios matter so much to BBUC?

Clarios is one of the largest and strongest assets in the portfolio. It is unlocking significant value by monetizing stakes and expanding into supercapacitors for AI data centers.

What is the biggest risk for BBUC right now?

CDK Global is the biggest named risk because its debt is trading at distressed levels. If CDK needs to restructure its debt, it could offset gains from stronger assets.

How does BBUC return money to investors?

BBUC can sell assets, sell partial stakes, refinance businesses, buy back shares, or make distributions. The model depends on getting cash out of private businesses at good prices.

07 Research standards

Sources and research notes

This page combines Finn's company research with public filings and other cited materials. The thesis is reviewed when material company information changes; Finn Scores use the latest available scoring data.

Thesis reviewed
November 8, 2026
Score data
November 15, 2026
Reviewed by
Shivam Bharuka
  1. BBUC Q3 2026 earnings transcript
  2. BBUC Q2 2026 earnings transcript
  3. Brookfield Business Partners 2025 20-F
08 Explore the industry

Comparable Asset Management companies

Companies near Brookfield Business Corporation in Finn's Asset Management industry ranking.

Get started with Finn today